BioScience Health Innovations, Inc.
BHIC
$4.13
-$0.05-1.20%
OTC PK
| 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | |
|---|---|---|---|---|---|
| Net Income | -153.87% | -2,436.00% | -115.66% | 516.85% | 899.25% |
| Total Depreciation and Amortization | -- | -- | -- | -- | -- |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | -- | -- | -- | -- | -- |
| Change in Net Operating Assets | -240.41% | 422.06% | -8,192.50% | -3,424.49% | -1,958.49% |
| Cash from Operations | -268.17% | -100.20% | -752.11% | 311.26% | 783.96% |
| Capital Expenditure | -- | -- | -- | -- | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | 43.16% | 100.00% | -- | -- |
| Cash from Investing | -- | 43.16% | 100.00% | -- | -- |
| Total Debt Issued | 26.90% | 131.03% | 275.68% | 332.17% | 153.22% |
| Total Debt Repaid | 71.26% | -203.22% | -233.07% | -292.35% | -82.45% |
| Issuance of Common Stock | -- | -- | -- | -- | -- |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | 1,433.63% | -191.82% | 25.26% | 111.48% | -44.54% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 32.07% | -245.00% | -184.52% | 431.57% | 396.34% |